V. Shepard Kirk's most recent trade in PDS Biotechnology Corporation was a trade of 200,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 22, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PDS Biotechnology Corporation | V. Shepard Kirk | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 200,000 | 200,000 | - | - | Employee Stock Option (Right to Buy) |